FUKUOKA, Japan--(BUSINESS WIRE)--Professor Ona’s laboratory at Kyushu University today announced the development of a rapid, high sensitive, label-free and non-invasive cell-based sensing technology for reliable efficacy prediction of anti-cancer and anti-metabolic syndrome compounds in their physiological concentrations. This technology senses dynamic cellular reaction against target compounds (including combined use) and determines their efficacy within 1 h after the compound addition regardless to the pharmaceutical mode of action. The results obtained are significantly related to conventional chemosensitivity tests that are quantitatively related to clinical tests in cancer. This technology will contribute to compound screening for personalized chemotherapy or preventive medicines such as anti-cancer, -Alzheimer disease, -aging (skin care), diabetes, pro-fat burning, -metabolism, -hair restoration and -body temp because of sensing mitochondria. This research results are presented at Bio Japan 2011.
